Wednesday, 18 September 2019

Biologics News

  • Samsung JV seeks second biosimilar approval in Europe

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2015

    Singapore: Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, has submitted marketing authorization application (MAA) for SB2, its Remicade (Infliximab) biosimilar ...Read more

  • Merck, China firm to co-develop DNA repair drug

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2013

    ‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, and commercialization agreement with BeiGene, a biotech R&D compa...Read more

  • Austrinova opens new facility in Singapore

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Singapore based biotech firm, Austrianova, has opened a new facility in Singapore to perform research and development and translational research activities for its cell encapsula...Read more

  • China Biologic subisdiary gets GMP tag

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Dec, 2014

    Singapore: Plasma-based biopharmaceutical company, China Biologic Products' subsidiary firm, Shandong Taibang Biological Products has received Good Manufacturing Practices certification fro...Read more

  • NUS team pioneers a novel technique to deliver biologicals

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2014

    Singapore: Researchers at the National University of Singapore have invented a novel technique to administer pain-killers and collagen into the body through a minimally invasive procedure. ...Read more

  • Hope for COPD: Network Verification Challenge

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2014

    Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chronic obstructive pulmonary disease (COPD) which are now available for re...Read more

  • Amgen unveils new plant in Asia

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Nov, 2014

    Singapore: US-based Amgen enters the Asian market with its new 'next-generation' biomanufacturing facility in Singapore. The plant is located in Tuas Biomedical Park. It will maufacture a m...Read more

  • A*STAR, Japanese bank ink partnership

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2014

    Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporation (SMBC) have inked a memorandum of understanding (MOU) to support ...Read more

  • AmpliPhi, SPH to combat antibiotic-resistant super bugs

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2012

    Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (SPS). The combination of the two companies would result in the creati...Read more

  • FUJIFILM expands cell manufacturing capacity

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2014

    Singapore: Gobal contract manufacturing firm, FUJIFILM Diosynth Biotechnologies, has expanded its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreacto...Read more

  • Biocon starts academy to train biotech professionals

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2013

    Bangalore: In a first for Asia's bioscience industry, India's leading biotech company, Biocon has started an academy to train biotech professional for the Indian and global industry in asso...Read more

  • Molecular painting sparks biologics research

    Biologics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    At the University of Veterinary Medicine in Vienna, Austria, Dr John Dangerfield and Dr Brian Salmons along with Dr Christoph Metzner developed a technology for quick and easy modification ...Read more

  • Making kidney dialysis cheaper and quicker

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2016

    Singapore: Scientists at the Indian Institute of Technology- Bombay, India have developed a unique membrane that can effectively reduce dialysis time and cut costs to almost 50 percent. The...Read more

  • Hospira recalls plum infusion pump for over blood delivery risk

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2014

    Singapore: FDA has stated that biologic drug company, Hospira, has identified an incorrect set component supplied and used during the manufacturing process of Hemostat Dual Channel Plum Set...Read more

  • Pharmaxis, Synairgen to develop drugs for fatal lung disease

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2015

    Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a research collaboration to develop a selective inhibitor to the lysyl oxi...Read more

  • BioTime appoints Adi Mohanty as COO

    Biologics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 30 Dec, 2014

    Singapore: Stem cell therapy company, BioTime, has appointed Mr Adi Mohanty, ex-Shire executive, as chief operating officer and would be reponsible to build BioTime's business through the d...Read more

  • Baxter inaugurates biologics facility in Singapore

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2014

    Singapore: Baxter International has launched an advanced recombinant biologic facility in Singapore. The suite supports the processing of ADVATE [Antihemophilic Factor (Recombinant)], full...Read more

  • Baxter recalls dialysis solution

    Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2014

    Singapore: Baxter is voluntarily initiating a recall of two lots of DIANEAL Low Calcium Peritoneal Dialysis Solution with 2.5 percent Dextrose 5000mL (Ambu-Flex II) to the hospital/user lev...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls